Profil

Grégoire Mélanie

Microbial technologies

Département GxABT > TERRA Research Centre

See author's contact details
Main Referenced Co-authors
Brossel, Hélène  (2)
Duysinx, Bernard  (2)
Fontaine, Alexis  (2)
Hamaïdia, Malik  (2)
Jamakhani, Majeed  (2)
Main Referenced Keywords
chemotherapy (2); eosinophils (2); cisplatin (1); malignant pleural mesothelioma (1); Mesothelioma (1);
Main Referenced Disciplines
Oncology (2)

Publications (total 2)

The most downloaded
28 downloads
Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798 https://hdl.handle.net/2268/303498

Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Willems, M., Jamakhani, M., Scherpereel, A., Wasielewski, E., Brossel, H., Fontaine, A., Hoyos, C., Grégoire, M., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Eosinophils inhibit malignant pleural mesothelioma response to chemotherapy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Contact ORBi